These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 21971252)

  • 1. [Advanced medical care system, highly advanced medical technology assessment system, and investigator-initiated registration-directed clinical trial].
    Fujiwara Y
    Rinsho Ketsueki; 2011 Oct; 52(10):1721-6. PubMed ID: 21971252
    [No Abstract]   [Full Text] [Related]  

  • 2. Effectiveness/efficacy difference too often ignored.
    Silverman E
    Manag Care; 2013 Jan; 22(1):36. PubMed ID: 23373138
    [No Abstract]   [Full Text] [Related]  

  • 3. [The medical advisory services of social health insurance].
    Hansis ML
    Zentralbl Chir; 2002 Dec; 127(12):1083-5. PubMed ID: 12529825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implementing evidence-based health policy in Washington State.
    Franklin GM; Budenholzer BR
    N Engl J Med; 2009 Oct; 361(18):1722-5. PubMed ID: 19864671
    [No Abstract]   [Full Text] [Related]  

  • 5. The limited state of technology assessment for medical devices: facing the issues.
    Ramsey SD; Luce BR; Deyo R; Franklin G
    Am J Manag Care; 1998 Sep; 4 Spec No():SP188-99. PubMed ID: 10185994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Technology development from the perspective of industry.
    Abele JE
    J Invasive Cardiol; 1993 Mar; 5(2):65-8. PubMed ID: 10171667
    [No Abstract]   [Full Text] [Related]  

  • 7. Some alternative perspectives concerning medical technology assessment.
    Diamond GA
    J Invasive Cardiol; 1992; 4(1):39-44. PubMed ID: 10149903
    [No Abstract]   [Full Text] [Related]  

  • 8. Update on the forthcoming European Clinical Investigation Standards.
    Donawa M
    Med Device Technol; 2002 Sep; 13(7):24-5. PubMed ID: 12397830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Joint report of the Council on Scientific Affairs and the Council on Medical Service. Technology assessment in medicine.
    Arch Intern Med; 1992 Jan; 152(1):46-50. PubMed ID: 1728928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The limited regulatory potential of medical technology assessment.
    Elhauge E
    Va Law Rev; 1996 Nov; 82(8):1525-1622. PubMed ID: 16715565
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of technology assessment in health benefits coverage for medical devices.
    Braslow NM; Shatin D; McCarthy DB; Newcomer LN
    Am J Manag Care; 1998 Sep; 4 Spec No():SP139-50. PubMed ID: 10185990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Obesity surgery: refusal of cost coverage despite medical expert assessment].
    Röggla G; Moser B
    Dtsch Med Wochenschr; 2006 Jun; 131(22):1289; author reply 1289. PubMed ID: 16755429
    [No Abstract]   [Full Text] [Related]  

  • 13. Medical evidence quality: a cause for uncertainty. Part II.
    Billings J
    Bus Health; 1988 Jan; 5(3):28-33. PubMed ID: 10302129
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of medical-technology strategies: effects of coverage and reimbursement (first of two parts).
    Bunker JP; Fowles J; Schaffarzick R
    N Engl J Med; 1982 Mar; 306(10):620-4. PubMed ID: 7035944
    [No Abstract]   [Full Text] [Related]  

  • 15. Experimental medical treatments: who should decide coverage?
    Collins JC
    Spec Law Dig Health Care Law; 1998 Jan; (226):9-45. PubMed ID: 10176412
    [No Abstract]   [Full Text] [Related]  

  • 16. Challenges ahead for federal technology assessment.
    Neumann PJ
    Health Aff (Millwood); 2007; 26(2):w150-2. PubMed ID: 17259197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Post launch studies].
    Akaza H; Ohashi Y; Shimada Y; Ikeda T; Saijo N; Isonishi S; Hirao Y; Tsuruo T; Tsukagoshi S; Sone S; Nakamura S; Kato M; Mikami O; von Euler M; Blackledge G; Milsted B; Vose B
    Gan To Kagaku Ryoho; 2002 Nov; 29(11):2037-48. PubMed ID: 12465411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How do cutting-edge treatments pass insurance muster?
    Parrish M
    Med Econ; 1998 May; 75(10):85-6, 89, 93-9. PubMed ID: 10179683
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of medical-technology strategies: proposal for an institute for health-care evaluation (second of two parts).
    Bunker JP; Fowles J; Schaffarzick R
    N Engl J Med; 1982 Mar; 306(11):687-92. PubMed ID: 7035949
    [No Abstract]   [Full Text] [Related]  

  • 20. Response: does the emperor have clothes?
    Owens DK
    Pharos Alpha Omega Alpha Honor Med Soc; 2000; 63(1):29-30. PubMed ID: 10752351
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.